Jonathan Kefas
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Neonatal Health and Biochemistry 2
- Co-authors
- Jodi M. Lestner (1 shared paper)Anthony M. Vandersteen (1 shared paper)Donald Harvey (1 shared paper)
- Journals
- The Lancet (7 papers)The Journal of Pediatrics (2 papers)Archives of Pediatrics and Adolescent Medicine (1 paper)EClinicalMedicine (1 paper)Transfusion Medicine (1 paper)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
Jonathan Kefas
16 papers receiving 1.8k citations
Jonathan Kefas's Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 964
- Applied Microbiology and Biotechnology 50
- Neurology 344
- Internal Medicine 56
- Obstetrics and Gynecology 91
Countries citing papers authored by Jonathan Kefas
This map shows the geographic impact of Jonathan Kefas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Kefas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Kefas more than expected).
Fields of papers citing papers by Jonathan Kefas
This network shows the impact of papers produced by Jonathan Kefas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Kefas. The network helps show where Jonathan Kefas may publish in the future.
Co-authors
The 3 scholars most cited alongside Jonathan Kefas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2016 | 197 | |
| 7 | 2023 | 83 | |
| 8 | 2021 | 27 | |
| 9 | 2023 | 24 | |
| 10 | 2024 | 23 | |
| 11 | 2012 | 12 | |
| 12 | 2025 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2008 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 2 |
About Jonathan Kefas
Jonathan Kefas is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Pharmacy, Genetics and Hematology, having authored 16 papers that have together received 1.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Neonatal Health and Biochemistry (2 papers), Neonatal Respiratory Health Research (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Erythrocyte Function and Pathophysiology (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Genetic Syndromes and Imprinting (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Infectious Diseases (964 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (344 citations), Internal Medicine (56 citations) and Obstetrics and Gynecology (91 citations). Jonathan Kefas has collaborated with scholars based in United Kingdom, Australia and Vietnam. Frequent co-authors include Jodi M. Lestner, Anthony M. Vandersteen and Donald Harvey. Their work appears in journals such as The Lancet, The Journal of Pediatrics, Archives of Pediatrics and Adolescent Medicine, EClinicalMedicine and Transfusion Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.